Downregulation of transforming growth factor, beta receptor 2 and Notch signaling pathway in human abdominal aortic aneurysm

Atherosclerosis

Volumn 221, Issue 2, 2012, Pages 383-386

  Biros, Erik ^a   Walker, Philip J ^b   Nataatmadja, Maria ^b   West, Malcolm ^b   Golledge, Jonathan ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Abdominal aortic aneurysm; Genetic aberrations; Marfan syndrome

Indexed keywords

FIBRILLIN 1; HEY2 PROTEIN; NOTCH RECEPTOR; NOTCH3 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; AORTIC SMOOTH MUSCLE CELL; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE FIBER;

AORTIC ANEURYSM, ABDOMINAL; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOPSY; CASE-CONTROL STUDIES; DNA COPY NUMBER VARIATIONS; DOWN-REGULATION; EXONS; GENE AMPLIFICATION; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HAPLOINSUFFICIENCY; HUMANS; MARFAN SYNDROME; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MUTATION; PROTEIN-SERINE-THREONINE KINASES; QUEENSLAND; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84858698938     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.004     Document Type: Article

References (39)

1. van Ooijen B. Marfan's syndrome and isolated aneurysm of the abdominal aorta. Br Heart J 1988, 59:81-84.
2. Dietz H.C., Cutting G.R., Pyeritz R.E., et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991, 352:337-339.
3. Collod G., Babron M.C., Jondeau G., et al. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet 1994, 8:264-268.
4. Pannu H., Fadulu V.T., Chang J., et al. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 2005, 112:513-520.
5. Attias D., Stheneur C., Roy C., et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 2009, 120:2541-2549.
6. Akhurst R.J. TGF beta signaling in health and disease. Nat Genet 2004, 36:790-792.
7. Golledge J., Muller J., Daugherty A., Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006, 26:2605-2613.
8. Conway A.M., Malkawi A.H., Hinchliffe R.J., et al. First-year results of a national abdominal aortic aneurysm screening programme in a single centre. Br J Surg 2011, 10.1002/bjs.7685.
9. Golledge J., Clancy P., Jones G.T., et al. Possible association between genetic polymorphisms in transforming growth factor b receptors, serum transforming growth factor b1 and abdominal aortic aneurysm. Br J Surg 2009, 96:628-632.
10. Baas A.F., Medic J., van't Slot R., et al. Association of the TGF-beta receptor genes with abdominal aortic aneurysm. Eur J Hum Genet 2010, 18:240-244.
11. Biros E., Norman P.E., Jones G.T., van Rij A.M., Yu G. Meta-analysis of the association between single nucleotide polymorphisms in TGF-β receptor genes and abdominal aortic aneurysm. Atherosclerosis 2011, 10.1016/j.atherosclerosis.2011.07.105.
12. Holm T.M., Habashi J.P., Doyle J.J., et al. Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 2011, 332:358-361.
13. Golledge J., Clancy P., Moran C., et al. The novel association of the chemokine CCL22 with abdominal aortic aneurysm. Am J Pathol 2010, 176:2098-2106.
14. Rose-Zerilli M.J., Barton S.J., Henderson A.J., Shaheen S.O., Holloway J.W. Copy-number variation genotyping of GSTT1 and GSTM1 gene deletions by real-time PCR. Clin Chem 2009, 55:1680-1685.
15. Qiao Y., Liu X., Harvard C., et al. Large-scale copy number variants (CNVs): distribution in normal subjects and FISH/real-time qPCR analysis. BMC Genomics 2007, 8:167.
16. Moody A., Sellers S., Bumstead N. Measuring infectious bursal disease virus RNA in blood by multiplex real-time quantitative RT-PCR. J Virol Methods 2000, 85:55-64.
17. Sijben J.W., Klasing K.C., Schrama J.W., Parmentier H.K., van der Poel J.J. Early in vivo cytokine genes expression in chickens after challenge with Salmonella typhimurium lipopolysaccharide and modulation by dietary n-3 polyunsaturated fatty acids. Dev Comp Immunol 2003, 27:611-619.
18. Weksberg R., Hughes S., Moldovan L., Bassett A.S., Chow E.W. A method for accurate detection of genomic microdeletions using real-time quantitative PCR. BMC Genomics 2005, 6:180.
19. Tang Y., Urs S., Boucher J., et al. Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem 2010, 285:17556-17563.
20. Weaver S., Dube S., Mir A., et al. Taking qPCR to a higher level: analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods 2010, 50:271-276.
21. Goumans M.J., Liu Z., ten Dijke P. TGF-beta signaling in vascular biology and dysfunction. Cell Res 2009, 19:116-127.
22. Toyoshima H., Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74.
23. Datto M.B., Li Y., Panus J.F., et al. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A 1995, 92:5545-5549.
24. Reynisdóttir I., Polyak K., Iavarone A., Massagué J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 1995, 9:1831-1845.
25. Tsai S., Hollenbeck S.T., Ryer E.J., et al. TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am J Physiol Heart Circ Physiol 2009, 297:H540-H549.
26. Li J.L., Harris A.L. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications. Front Biosci 2009, 14:3094-3110.
27. Zavadil J., Cermak L., Soto-Nieves N., Böttinger E.P. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004, 23:1155-1165.
28. Loeys B.L., Chen J., Neptune E.R., et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005, 37:275-281.
29. Loeys B.L., Schwarze U., Holm T., et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006, 355:788-798.
30. Maleszewski J.J., Miller D.V., Lu J., Dietz H.C., Halushka M.K. Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS). Am J Surg Pathol 2009, 33:194-201.
31. Lee M.K., Pardoux C., Hall M.C., et al. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 2007, 26:3957-3967.
32. Habashi J.P., Doyle J.J., Holm T.M., et al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 2011, 332:361-365.
33. Redondo S., Ruiz E., Gordillo-Moscoso A., et al. Role of TGF-beta1 and MAP kinases in the antiproliferative effect of aspirin in human vascular smooth muscle cells. PLoS One 2010, 5:e9800.
34. Sweeney C., Morrow D., Birney Y.A., et al. Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway. FASEB J 2004, 18:1421-1423.
35. Morrow D., Scheller A., Birney Y.A., et al. Notch-mediated CBF-1/RBP-J{kappa}-dependent regulation of human vascular smooth muscle cell phenotype in vitro. Am J Physiol Cell Physiol 2005, 289:C1188-C1196.
36. López-Candales A., Holmes D.R., Liao S., et al. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 1997, 150:993-1007.
37. Satta J., Mennander A., Soini Y. Increased medial TUNEL-positive staining associated with apoptotic bodies is linked to smooth muscle cell diminution during evolution of abdominal aortic aneurysms. Ann Vasc Surg 2002, 16:462-466.
38. Zhang J., Schmidt J., Ryschich E., Schumacher H., Allenberg J.R. Increased apoptosis and decreased density of medial smooth muscle cells in human abdominal aortic aneurysms. Chin Med J 2003, 116:1549-1552.
39. Clarke M.C., Figg N., Maguire J.J., et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006, 12:1075-1080.